These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 2899387)

  • 1. New alpha 1-adrenergic receptor antagonists for the treatment of hypertension: role of vascular alpha receptors in the control of peripheral resistance.
    Cubeddu LX
    Am Heart J; 1988 Jul; 116(1 Pt 1):133-62. PubMed ID: 2899387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective alpha 1-adrenergic antagonists: therapeutically relevant antihypertensive agents.
    Graham RM
    Am J Cardiol; 1984 Jan; 53(3):16A-20A. PubMed ID: 6141721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular profile and hypotensive mechanism of ketanserin in the rabbit.
    Bolt GR; Saxena PR
    Hypertension; 1985; 7(4):499-506. PubMed ID: 2861161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacologic profile of urapidil. Consequences for use as an antihypertensive drug].
    van Zwieten PA
    Fortschr Med; 1992 Jun; 110(17):330-2. PubMed ID: 1353745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and chronic hemodynamic effects of drugs with different actions on adrenergic receptors: a comparison between alpha blockers and different types of beta blockers with and without vasodilating effect.
    Lund-Johansen P; Omvik P
    Cardiovasc Drugs Ther; 1991 Jun; 5(3):605-15. PubMed ID: 1678963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha 2-adrenergic receptors and calcium: alpha 2-receptor blockade in vascular smooth muscle as an approach to the treatment of hypertension.
    Lee JY; DeBernardis JF
    Methods Find Exp Clin Pharmacol; 1990 Apr; 12(3):213-25. PubMed ID: 1972206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of the use of alpha-adrenoceptor antagonists in hypertension.
    Stokes GS; Marwood JF
    Methods Find Exp Clin Pharmacol; 1984 Apr; 6(4):197-204. PubMed ID: 6146746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of alpha adrenoceptors in hypertension and in antihypertensive drug treatment.
    Van Zwieten PA; Timmermans PB; Van Brummelen P
    Am J Med; 1984 Oct; 77(4A):17-25. PubMed ID: 6148891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New developments in alpha-adrenergic receptor pharmacology: implications for the initial treatment of hypertension.
    Colucci WS
    Am J Cardiol; 1983 Feb; 51(4):639-43. PubMed ID: 6131604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
    Itskovitz HD
    Clin Ther; 1994; 16(3):490-504. PubMed ID: 7923316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacotherapeutics of doxazosin.
    Taylor SH
    Am J Med; 1989 Aug; 87(2A):2S-11S. PubMed ID: 2569822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacology and therapeutic role of prazosin and related alpha-adrenoceptor antagonists.
    Reid JL; Vincent J
    Cardiology; 1986; 73(3):164-74. PubMed ID: 2872958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and trends in the drug treatment of essential hypertension.
    van Zwieten PA
    J Hypertens Suppl; 1992 Dec; 10(7):S1-12. PubMed ID: 1363322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of alpha receptor types to hypotension and renal vasodilation caused by alpha blockers in conscious dogs.
    Zimmerman BG; Largent RD
    Hypertension; 1983; 5(2 Pt 2):I170-4. PubMed ID: 6131031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT, alpha-adrenoceptors, and blood pressure. Effects of ketanserin in essential hypertension and autonomic insufficiency.
    Wenting GJ; Woittiez AJ; Man in't Veld AJ; Schalekamp MA
    Hypertension; 1984; 6(1):100-9. PubMed ID: 6319278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapeutic stature of doxazosin and its role in coronary risk reduction.
    Taylor SH
    Am Heart J; 1988 Dec; 116(6 Pt 2):1735-47. PubMed ID: 2904744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha- and beta-receptor blocking drugs in the treatment of hypertension.
    Ram CV; Kaplan NM
    Curr Probl Cardiol; 1979 Jan; 3(10):1-53. PubMed ID: 40755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of reflex tachycardia by central administration of the alpha-1 adrenoceptor antagonists urapidil and prazosin in anesthetized dogs.
    Shebuski RJ; Zimmerman BG
    J Pharmacol Exp Ther; 1985 Aug; 234(2):456-62. PubMed ID: 2862276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive therapy in the geriatric patient: II. A review of the alpha1-adrenergic blocking agents.
    Studer JA; Piepho RW
    J Clin Pharmacol; 1993 Jan; 33(1):2-13. PubMed ID: 8094084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and pharmacodynamic properties and therapeutic use of bunazosin in hypertension. A review.
    Weidinger G
    Arzneimittelforschung; 1995 Nov; 45(11):1166-71. PubMed ID: 8929232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.